Latest AI and machine learning research in other cancers for healthcare professionals.
Glioma is a highly aggressive brain tumor characterized by a profoundly immunosuppressive tumor microenvironment dominated by M2-polarized tumor-associated macrophages (TAMs). This study utilized machine learning and single-cell multi-omics technologies to investigate the role of LILRB3 in glioma immunosuppression and evaluated the therapeutic potential of BM@nano-siLILRB3. In a tumor-bearing mous...
The distribution of produced isotopes during proton therapy can be imaged with Positron Emission Tomography (PET) to verify dose delivery. However, biological washout, driven by tissue-dependent processes such as perfusion and cellular metabolism, reduces PET signal-to-noise ratio (SNR) and limits quantitative analysis. In this work, we propose an uncertainty-aware deep learning framework to impro...
Pulmonary sarcoidosis is a heterogeneous granulomatous disease with an unpredictable clinical course, in which accurate assessment of disease activity...
Understanding how genetic variation contributes to organism-wide phenotypes is critical for identifying mechanisms of disease. Here, we present a comp...
OBJECTIVE: ACTH-dependent Cushing's syndrome (CS) causes profound immune dysfunction and severe infections. This study aimed to characterize immune ce...
Clear cell renal cell carcinoma (ccRCC) is an aggressive malignancy with a high risk of postoperative recurrence. Body composition has emerged as a pr...
OBJECTIVE: To develop and validate a robust, multimodal machine learning framework integrating radiomic and deep learning features from multiplex immu...
BACKGROUND/AIMS: Intrahepatic cholangiocarcinoma (iCCA) represents an unmet clinical need due to its increasing incidence, aggressive biology, and lim...
RATIONALE AND OBJECTIVE: The status of cervical lymph node metastasis(LNM) in Papillary thyroid carcinoma(PTC) can affect the patient's treatment plan...
BACKGROUND AND OBJECTIVE: Differentiating T1-stage nasopharyngeal carcinoma (NPC) from benign hyperplasia (BH) is challenging. This study aims to cons...
Predicting pathological complete response (pCR) to neoadjuvant therapy (NAT) in breast cancer remains challenging due to high tumor heterogeneity and ...
Malignant stroke is a life-threatening condition, with mortality rates reaching up to 80% among patients managed conservatively. Brain swelling volume...
BACKGROUND: Microscopic, immunologic, and chemical testing play a major role in the diagnostic process of hematologic cancer patients. Pathologists re...
Lung cancer (LC) is one of the leading causes of death globally. Early detection is essential for saving lives and ensuring effective treatment for pa...
BACKGROUND: Predicting response to immune checkpoint inhibitor plus tyrosine kinase inhibitor (IO+TKI) therapy in metastatic renal cell carcinoma (mRC...
Metabolic dysfunction-associated steatohepatitis (MASH) represents a growing global health challenge due to its propensity to progress to irreversible...
BACKGROUND: Oral cavity squamous cell carcinoma (OSCC) is a global health burden, where negative margins are essential for reducing recurrence and imp...
Tumor tissue engineering, integrating organoid, microfluidic, and biofabrication technologies, has opened new avenues for cancer research. Leveraging ...
UNLABELLED: Metastasis is the leading cause of cancer deaths. To develop strategies for intercepting metastatic progression, a better understanding of...
UNLABELLED: Pediatric sarcomas present diagnostic challenges due to their rarity and diverse subtypes, often requiring specialized pathology expertise...